GRHL2 and neoplasm: As listed in Table S1, the single variable analyses of distant metastasis-free survival (DMFS) for GRHL2 and four clinical prognostic factors (ER status, lymph node status, tumor size and tumor grade) are significant (log-rank tested p<0.05).